Doxycycline

• Efficacy and safety of Dalbavancin in the treatment of infective Endocarditis caused by gram-positive cocci Pending
  2026-526149-91-00 Phase III 1 country Friedrich-Schiller-Universitaet Jena
• Doxycycline post-exposure prophylaxis: Weekly versus event-driven Intake for STI prevention among MSM and TGW taking PrEP Recruiting
  2025-524823-34-00 Phase III 1 country Institute Of Tropical Medicine
• Randomized clinical trial to compare oral isotretinoin to standard of care in moderate acne skin of color patients Recruiting
  2023-507519-36-00 Phase III 1 country Centre Hospitalier Universitaire De Nice
• Impact of rifampicin in treatment outcome of Cutibacterium spp. prosthetic joint infections - RIFACute Recruiting
  2022-502974-18-00 Phase II/III 1 country Centre Hospitalier Universitaire De Nice
• Staphylococcus aureus Network Adaptive Platform trial (SNAP) Recruiting
  2023-503582-35-00 Phase IV 4 countries University Medical Center Utrecht
• The RiCOTTA study: Rifampicin Combination Therapy versus Targeted Antibiotic Monotherapy for Infected Joint Prostheses Caused by Staphylococ… Recruiting
  2022-501620-26-00 Phase IV 1 country Leiden University Medical Center
• Finding the best treatment for lung disease from infection with Mycobacterium abscessus Recruiting
  2023-506575-99-00 Phase II 1 country The University Of Queensland
• Phenosar Ended
  2024-513534-38-00 Phase IV 1 country Sint Antonius Ziekenhuis Stichting
• Clinical trial addressing the efficacy of first-line Chlamydophila psittaci-eradicating therapy with protracted administration of doxycyclin… Ended
  2024-513426-29-00 Phase II 1 country Association International Extranodal Lymphoma Study Group (IELSG)

Showing 1–9 of 9 trials